ClinicalTrials.gov record

Terminated Not applicable Interventional Accepts healthy volunteers Results available

Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep

ClinicalTrials.gov ID: NCT02189213

Public ClinicalTrials.gov record NCT02189213. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 7, 2026, 9:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT02189213
Recruitment status: Terminated
Study type: Interventional
Phase: Not applicable
Lead sponsor: New York State Psychiatric Institute; Other
Enrollment: 14 participants

Conditions and interventions

Conditions

Interventions

Sertraline Drug

Drug

Eligibility (public fields only)

Age range: 8 Years to 25 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 30, 2014
Primary completion: Nov 30, 2019
Completion: Nov 30, 2019
Last update posted: Oct 10, 2021

2014 – 2019

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
NYSPI	New York	New York	10032	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02189213, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 10, 2021 · Synced May 7, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02189213 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →